BlueCrest Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-45,280	Closed	-$231K	–	650
2019 Q1	$231K	Buy	45,280 +13,666	+43%	+$69.7K	0.01%	854
2018 Q4	$108K	Buy	+31,614	New	+$108K	0.01%	743
2018 Q2	–	Sell	-101,406	Closed	-$481K	–	1571
2018 Q1	$481K	Buy	+101,406	New	+$481K	0.02%	775